The GLP-1 wake-up call for food makers: Appetite loss is exposing ‘weak’ products

BakeryAndSnacks.com·Feb 11

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The emergence of GLP-1 weight-loss drugs is reportedly altering eating habits and food preferences in the US. Food companies are responding to these changes by rebranding and reformulating their products. The impact of these drugs on the food industry is still unfolding, with some outlets noting changes in demand and menu offerings, while others discuss potential alternatives to the drugs for appetite control.

Full coverage

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

UCHealth·Jun 16

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

CNBC·Mar 21

Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus

NBC News·Jan 20

What is Zepbound? Does this weight-loss drug work better than Wegovy and Ozempic?

UCHealth·May 18

View original report at BakeryAndSnacks.com ↗

Fetching the latest headlines…

The GLP-1 wake-up call for food makers: Appetite loss is exposing ‘weak’ products

Full coverage

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

Big Food pours millions into rebrands as obesity drugs reshape US demand

GLP‑1s are quietly rewriting the grocery list

Exercise and L-leucine supplementation may improve appetite control: Study

Arrival of GLP-1 weight-loss pill creates new headache for food, drink makers

Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus

What is Zepbound? Does this weight-loss drug work better than Wegovy and Ozempic?